Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Marc A. Pfeffer(Brigham and Women's Hospital), Jean‐Claude Tardif(Montreal Heart Institute), Eldrin F. Lewis(Brigham and Women's Hospital), John J.V. McMurray(University of Glasgow), Lars Køber(University of Copenhagen), Xiaodan Wei(Sanofi (United States)), Brian Claggett(Brigham and Women's Hospital), Francesca Lawson(Sanofi (United States)), Scott D. Solomon(Brigham and Women's Hospital), Matthew C. Riddle(Oregon Health & Science University), Aldo P. Maggioni(Health Care Foundation), Lin Ping(Sanofi (United States)), Kenneth Dickstein(Stavanger University Hospital), Rafael Díaz(Estudios Clínicos Latinoamérica), Jeffrey L. Probstfield(University of Washington Medical Center), Hertzel C. Gerstein(McMaster University)
Cited by 2,329
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k